ClinicalTrials.Veeva

Menu

Supplemental Perioperative Oxygen to Reduce the Incidence of Post-cesarean Wound Infection

S

Saint Thomas Hospital (HST)

Status and phase

Completed
Phase 3

Conditions

Surgical Wound Infection

Treatments

Device: Supplemental oxygen 80% FIO2
Procedure: Use of air (no oxygen during surgery)

Study type

Interventional

Funder types

Other

Identifiers

NCT01340534
MHST2011-02

Details and patient eligibility

About

The purpose of this study is to determine if the use of supplemental oxygen at 80% FIO2 can reduce the incidence of surgical site infection after emergency cesarean section.

Full description

Surgical site infection (SSI) is one of the most important complications that can develop after a cesarean section. SSI can be mild or it can develop into septic shock and death, being cesarean section the most important cause of puerperal infections. Supplemental oxygen at high doses has been advocated as a protective factor for SSI. The purpose of this study is to determine if the use of oxygen at high doses (80% FIO2)can reduce the incidence of SSI after emergency cesarean section.

Enrollment

370 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gestational age > 37 weeks
  • Emergency cesarean section
  • Regional Anesthesia

Exclusion criteria

  • Elective cesarean section
  • Fever of unknown origin at admission
  • Twin pregnancy
  • Chorioamnionitis
  • Acute fetal distress that requires general anesthesia
  • Immunocompromise
  • Maternal Lung/Respiratory Disease

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

370 participants in 2 patient groups, including a placebo group

Oxygen 80% FIO2
Experimental group
Description:
Group of 181 patients that will receive supplemental oxygen 80% FIO2 during surgery (cesarean) and two hours after the procedure.
Treatment:
Device: Supplemental oxygen 80% FIO2
Use of air (no oxygen during surgery)
Placebo Comparator group
Description:
Group of 181 patients that will not receive supplemental oxygen during surgery (cesarean).
Treatment:
Procedure: Use of air (no oxygen during surgery)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems